Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
QuidelOrtho
QDEL
$1.21B
| $1.03M | ﹤0.01% |
9,161
-1,838
| -17% | -$196K |
|
2302
e.l.f. Beauty
ELF
$4.87B
| $1.03M | ﹤0.01% |
39,808
-24,304
| -38% | -$661K |
|
2303
Helen of Troy
HELE
$676M
| $1.03M | ﹤0.01% |
5,250
-28,691
| -85% | -$6.04M |
|
2304
US Physical Therapy
USPH
$1.18B
| $1.03M | ﹤0.01% |
10,344
-6,359
| -38% | -$606K |
|
2305
Metallus
MTUS
$851M
| $1.03M | ﹤0.01% |
46,904
-39,176
| -46% | -$689K |
|
|
OTRA
2306
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
|
FOLD
2307
DELISTED
Amicus Therapeutics
FOLD
| $1.01M | ﹤0.01% |
107,218
-219,041
| -67% | -$2.05M |
|
2308
Penumbra
PEN
$12.7B
| $1.01M | ﹤0.01% |
4,569
-3,931
| -46% | -$873K |
|
|
GRVY
2309
GRAVITY
GRVY
$429M
| $1.01M | ﹤0.01% |
20,007
-20,219
| -50% | -$1.13M |
|
|
SNP
2310
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $1.01M | ﹤0.01% |
20,466
| – | – |
|
|
RDUS
2311
DELISTED
Radius Health, Inc.
RDUS
| $1.01M | ﹤0.01% |
114,716
+37,893
| +49% | +$287K |
|
2312
NCR Voyix
VYX
$1.19B
| $1.01M | ﹤0.01% |
40,972
-21,558
| -34% | -$530K |
|
|
ADAL
2313
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
| $1.01M | ﹤0.01% |
+101,499
| New | +$1M |
|
2314
Kratos Defense & Security Solutions
KTOS
$9.23B
| $1.01M | ﹤0.01% |
49,182
-118,050
| -71% | -$2.15M |
|
|
CAS
2315
DELISTED
Cascade Acquisition Corp.
CAS
| $1.01M | ﹤0.01% |
+100,000
| New | +$1M |
|
|
CDMO
2316
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.01M | ﹤0.01% |
49,457
-29,490
| -37% | -$600K |
|
2317
Photronics
PLAB
$1.85B
| $1M | ﹤0.01% |
59,206
-30,772
| -34% | -$554K |
|
2318
United Parks & Resorts
PRKS
$2.15B
| $1M | ﹤0.01% |
13,508
-57,224
| -81% | -$3.75M |
|
2319
Kura Oncology
KURA
$816M
| $1M | ﹤0.01% |
62,489
-63,157
| -50% | -$912K |
|
2320
Sturm, Ruger & Co
RGR
$616M
| $1M | ﹤0.01% |
14,423
-8,199
| -36% | -$564K |
|
2321
Cars.com
CARS
$676M
| $1M | ﹤0.01% |
69,335
-25,251
| -27% | -$388K |
|
2322
Schrodinger
SDGR
$1.14B
| $1M | ﹤0.01% |
+29,360
| New | +$892K |
|
2323
Collegium Pharmaceutical
COLL
$1.15B
| $998K | ﹤0.01% |
49,026
-23,565
| -32% | -$445K |
|
2324
Movado Group
MOV
$866M
| $998K | ﹤0.01% |
25,559
-9,933
| -28% | -$377K |
|
2325
Arbutus Biopharma
ABUS
$861M
| $997K | ﹤0.01% |
334,796
+63,342
| +23% | +$194K |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.